MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-24-0003770
Medoz Pharmaceuticals Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.36 Cr
▲ 6% YoY
Net profit · FY 2025
₹27.52 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹94.47 Lakh
EBITDA margin 7.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹62.11 Lakh
Issued & subscribed
Open charges
₹7.26 Cr
Satisfied ₹4.98 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
27
Provident fund records
About Medoz Pharmaceuticals Private Limited
Data last updated:
Medoz Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2000PTC037288. Its GSTIN is 02AACCM4069N2ZB (Himachal Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹62.11 Lakh. It is led by directors Rakesh Jambuprasad Agrawal (Managing Director) and Parmar Rameshkumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 418 Payal Complex Sayajigunj, Vadodara, Gujarat, India – 390020.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.36 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹27.52 Lakh (net margin 2.1%) and EBITDA of ₹94.47 Lakh (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Medoz Pharmaceutical. As per MCA filings, the company has open charges of ₹7.26 Cr and satisfied charges of ₹4.98 Cr on record. Court records list 8 cases involving the company, including 6 filed by the company and 2 filed against it; 2 cases are pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹85.3 Lakh; the latest was in March 2025. Its 4 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is KNM Pharma Private Limited with revenue of ₹13.41 Cr.
Medoz Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0003770). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medozpharmaceuticals.com.
Company details
CIN U24231GJ2000PTC037288
Registration Number 037288
Incorporation Date 02 February 2000
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0003770
Recognitions & Rankings of Medoz Pharmaceuticals
Contact details
Medoz Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is medozpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address418 Payal Complex Sayajigunj, Vadodara, Gujarat, India – 390020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medoz Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medoz Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medoz Pharmaceuticals operates one associated brand: Medoz Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical drugs with global distribution. | medozpharmaceuticals.com |
Business activity
The main business activity of Medoz Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medoz Pharmaceuticals Private Limited, buy the company report.
Financials of Medoz Pharmaceuticals Private Limited
FY 2025 filings availableMedoz Pharmaceuticals Private Limited reported revenue of ₹13.36 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹13.36 Cr ▲ 6%
Net profit · FY 2025
₹27.52 Lakh margin 2.1%
EBITDA · FY 2025
₹94.47 Lakh margin 7.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 3%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 5%
5 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 6% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.52 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medoz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medoz Pharmaceuticals Private Limited
Medoz Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parmar Rameshkumar | Director | 18 Sep 2019 | 7 Years 1 Months | Current |
| Rakesh Jambuprasad Agrawal | Managing Director | 02 Feb 2000 | 26 Years 8 Months | Current |
Peer comparison
Medoz Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KNM Pharma Private Limited | ₹13.41 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Seagull Laboratories (India) Private Limited | ₹13.38 Cr (FY 2024) | -2.0% | New Delhi, Delhi, India | |||
| Southern Union Pharmaceuticals Kerala Private Limited | ₹13.37 Cr (FY 2025) | -10.0% | Thrissur, Kerala, India | |||
| Medoz Pharmaceuticals Private Limitedthis company | ₹13.36 Cr (FY 2025) | ₹27.52 Lakh | 2.1% | 6.0% | 27 | Vadodara, Gujarat, India |
| Pharmacare Aura Private Limited | ₹13.33 Cr (FY 2025) | 64.0% | Paonta Sahib, Himachal Pradesh, India |
To see the full peer comparison of Medoz Pharmaceuticals Private Limited, buy the company report.
Auditor
Medoz Pharmaceuticals Private Limited is audited by Nilesh Subhash Agrawal & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nilesh Subhash Agrawal & Associates | FY 2024 | 011427C |
Shareholding
The shareholding of Medoz Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medoz Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.26 Cr
Satisfied charges
₹4.98 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2024 | 100966810 | Others | ₹19.58 Lakh | Open | |
| 02 Nov 2020 | 100401690 | Canara Bank | ₹17 Lakh | Open | |
| 25 Sep 2019 | 100289988 | Others | ₹6.6 Cr | Open | |
| 21 Feb 2011 | 10269577 | Director of Industries Himachal Pradesh | ₹30 Lakh | Open | |
| 09 Mar 2021 | 100444656 | Hdfc Bank Limited | ₹3.39 Cr | Satisfied |
To see the full charge records of Medoz Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Medoz Pharmaceuticals Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹85.3 Lakh; the latest was in March 2025.
Total deals
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹85.3 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2009 | Funding round | ₹28 Lakh | Investors: Warner Multimedia Limited , Jolly Multimedia Private Limited |
| Mar 2008 | Funding round | ₹57.3 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Medoz Pharmaceuticals Private Limited has 8 court cases on record: 6 filed by Medoz Pharmaceuticals, 2 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
6
Filed against the company
2
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 1 |
| High courts | 3 | 2 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Laboratoires Griffon Pvt Ltd and Anr and 1 other | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Shubhansh Pharmaceuticals and 1 other | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Satyam Brothers and 1 other | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr. | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against DRX Quest Pharmaceuticals and 2 others | Disposed |
To see the full case history of Medoz Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medoz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medoz Pharmaceuticals Private Limited has a workforce of 27 employees on its EPFO records as of Feb 17, 2026, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
-27.03%
GST
Medoz Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCM4069N2ZB | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medoz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medoz Pharmaceuticals Private Limited has 6 board changes on record since 2000: 2 appointments and 4 cessations. The latest: Anil Kumar Agarwal ceased to be Director on 16 Dec 2019.
AGM
Medoz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medoz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100966810 was registered on 24 Jul 2024.
Charges
A charge with Others of Rs. 6.60 Cr registered on 25 Sep 2019 with Charge ID 100289988 was modified on 22 Jul 2024.
Charges
A charge registered on 09 Mar 2021 via Charge ID 100444656 with Hdfc Bank Limited was fully satisfied on 22 Apr 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.39 Cr with Charge ID 100444656 was registered on 09 Mar 2021.
Charges
A charge with Canara Bank amounted to Rs. 0.17 Cr with Charge ID 100401690 was registered on 02 Nov 2020.
Ceased
Anil Kumar Agarwal ceased to be Director.
Charges
A charge registered on 08 Mar 2006 via Charge ID 10003211 with State Bank Of Patiala was fully satisfied on 13 Dec 2019.
Charges
A charge with Others amounted to Rs. 6.60 Cr with Charge ID 100289988 was registered on 25 Sep 2019.
Appointed
Parmar Rameshkumar was appointed as Director.
Ceased
Jambukumar Jain ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Medoz Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 2000 (26+ years old) and is registered under CIN U24231GJ2000PTC037288.
Medoz Pharmaceuticals has 2 current directors:
- Rakesh Jambuprasad Agrawal - Managing Director
- Parmar Rameshkumar - Director
The latest financial statements of Medoz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medoz Pharmaceuticals is 02AACCM4069N2ZB, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Medoz Pharmaceuticals is U24231GJ2000PTC037288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medoz Pharmaceuticals has 8 court cases on record: 6 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Medoz Pharmaceuticals was incorporated on 02 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Medoz Pharmaceuticals has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹85.3 Lakh; the latest was in March 2025.
The peers of Medoz Pharmaceuticals by revenue are KNM Pharma Private Limited, Seagull Laboratories (India) Private Limited, Southern Union Pharmaceuticals Kerala Private Limited, Pharmacare Aura Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Kumar Agarwal ceased to be Director on 16 Dec 2019. Parmar Rameshkumar was appointed as Director on 18 Sep 2019. Jambukumar Jain ceased to be Director on 10 Apr 2019. Medoz Pharmaceuticals has 6 board changes on record in total.
Yes, Medoz Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0003770).